Innovations in Primary Packaging for High-Value Biologics

To view on-demand, please fill our short form

*
Captcha verification required

Biologics occupy a growing share of the current drug market and the drug development pipeline. The high value of new advanced therapies combined with their unique storage and handling requirements intensify the need for a reliable container closure system. Innovations in glass vial and elastomer stopper technology are now available to address packaging challenges, including reduced E&L profile, particle contamination, mechanical reliability, and compatibility with cold storage.

This webinar will outline:

  • Common characteristics of biologics product that influence packaging component selection
  • Corning® Valor® vials and West NovaPure® stoppers as tools to protect your high value biologics
  • Ready Pack® containment solution, designed to de-risk your development pipeline and increase speed to market

Aubrey Jeter

Aubrey Jeter

Technical Account Specialist, West Pharmaceutical Services

Aubrey Jeter is a member of the North American Technical Customer Support team with West Pharmaceutical Services. In this role, Jeter addresses technical questions and concerns regarding West products and processes, including making primary injectable packaging recommendations to align with the customer’s requirements for quality and safety. Jeter supports multi-national customers in various drug product spaces, including cell and gene therapies, advanced biologics, and small and large molecule therapies. Jeter graduated from Pennsylvania State University with a degree in Animal Science.
Mathew Hall

Mathew Hall

Technical Affairs Director, Corning Pharmaceutical Technologies

Dr. Matthew Hall is the Technical Affairs Director for Corning Pharmaceutical Technologies, a manufacturer of pharmaceutical glass tubing and containers for parenteral drug products. A member of the commercial team, Hall serves as a technical expert in support of sales and marketing functions and as a liaison to the larger pharmaceutical industry ecosystem. Hall holds a BS degree in Ceramic Engineering from the Missouri University of Science & Technology, MS and PhD degrees in Glass Science from Alfred University, and an MBA degree from the University of Rochester.